Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer

Background: Dyspnea is a severe symptom of terminal-stage interstitial pneumonia (IP). We commonly use continuous morphine or midazolam for terminal refractory dyspnea. Objective: We aimed to determine whether there is a difference in the use of continuous morphine and midazolam for terminal dyspnea...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hiroko Okabayashi, Hideya Kitamura, Satoshi Ikeda, Akimasa Sekine, Tsuneyuki Oda, Tomohisa Baba, Eri Hagiwara, Takuro Sakagami, Takashi Ogura
Format:	Artigo
Jezik:	Inglês
Izdano:	SAGE Publishing 2021-06-01
Serija:	Palliative Medicine Reports
Teme:	interstitial pneumonia lung cancer midazolam morphine palliative care palliative sedatives
Online dostop:	https://www.liebertpub.com/doi/full/10.1089/PMR.2021.0010
Oznake:	Označite Brez oznak, prvi označite!